Retrospective Observational Study to Compare Cystic Fibrosis Patients in Two Decades Before and After 2000
NCT01651455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 92
Last updated 2013-07-31
Summary
The purpose of this study is to describe two cohorts of cystic fibrosis patients treated in 2 different decades in terms of FEV1 (Forced Expiratory Volume in one second) maintenance.
Conditions
Sponsors & Collaborators
-
Medidata Solutions
collaborator INDUSTRY -
Chiesi Farmaceutici S.p.A.
lead INDUSTRY
Principal Investigators
-
Baroukh Maurice Assael, Professor · U.O. Fibrosi Cistica Azienda Ospedaliera Verona
Eligibility
- Min Age
- 10 Years
- Max Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-09-30
- Primary Completion
- 2013-03-31
- Completion
- 2013-06-30
Countries
- Italy
Study Locations
More Related Trials
-
A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease
NCT00311506 ·Status: COMPLETED
-
Evaluating Sensations of Breathlessness in Patients With Cystic Fibrosis
NCT01799642 ·Status: COMPLETED
-
Sleep in Patients With Cystic Fibrosis
NCT00804661 ·Status: COMPLETED
-
Observational Trial of the Longitudinal Effects of CFTR Modulator Drugs
NCT04353752 ·Status: COMPLETED
-
Cardiopulmonary Fitness in Children With Cystic Fibrosis Compared to Healthy Children
NCT06242951 ·Status: COMPLETED
-
Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis
NCT02767297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Home Monitoring to Predict Exacerbation in Cystic Fibrosis
NCT02416375 ·Status: COMPLETED
-
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects
NCT03093714 ·Status: COMPLETED ·Phase: PHASE1
-
6 Minute Walk Test in Cystic Fibrosis
NCT02538575 ·Status: COMPLETED ·Phase: NA
-
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
NCT02477319 ·Status: COMPLETED
-
Cystic Fibrosis and Frailtyh What's in Common?
NCT06020547 ·Status: COMPLETED
-
Response to CFTR Modulators in CF Patients Under 18 Years
NCT04301856 ·Status: RECRUITING
-
Microbiome Acquisition and Progression of Inflammation and Airway Disease in Infants and Children With Cystic Fibrosis
NCT01661491 ·Status: COMPLETED
-
Health Outcomes of Parents With Cystic Fibrosis-Aim 2
NCT06296394 ·Status: RECRUITING
-
Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure.
NCT00208078 ·Status: TERMINATED ·Phase: PHASE4
-
Comparison of the Tolerability of Two Formulations of Hypertonic Saline in Cystic Fibrosis Patients
NCT01658449 ·Status: COMPLETED ·Phase: NA
-
Molecular Phenotypes for Cystic Fibrosis Lung Disease
NCT01116414 ·Status: COMPLETED
-
Cough Efficiency in Cystic Fibrosis
NCT01636219 ·Status: COMPLETED
-
Evaluation of the Lung Clearance Index
NCT02342951 ·Status: COMPLETED ·Phase: NA
-
Oxygen Therapy in Cystic Fibrosis
NCT01586728 ·Status: TERMINATED ·Phase: NA
-
A Study of RPL554 in Patients With Cystic Fibrosis
NCT02919995 ·Status: COMPLETED ·Phase: PHASE2
-
Respiratory Function, Exercise Capacity and Peripheral Muscle Strength Among Patients With CF, PCD and Healthy Children
NCT04161313 ·Status: COMPLETED
-
The Effect of Hypertonic Saline on the Lung Clearance Index in Patients With Cystic Fibrosis
NCT00635141 ·Status: COMPLETED ·Phase: PHASE3
-
Health Outcomes of Parents With Cystic Fibrosis
NCT05829694 ·Status: COMPLETED